Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen muted as investors eye earnings, Fed meeting

(Sharecast News) - London stocks were set for a muted open on Tuesday as investors mull results from the likes of Unilever, Compass Group and Croda and eye the start of the Federal Reserve's two-day policy meeting. The FTSE 100 was called to open down around five points.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The Fed starts its two-day policy meeting in just a couple of hours from now, and will highly likely announce a 25bp hike on Wednesday.

"But what Fed officials will also do is to remind investors that the tightening cycle is probably not over and that there will probably be another rate hike on the US' horizon. So yes, there is a great chance that the Fed will spoil your mood if you are among those thinking that this week's rate hike will be the last for this tightening cycle in the US."

In UK corporate news, consumer goods giant Unilever delivered a 3.3% rise in interim earnings driven by higher prices and said it expected underlying price growth to moderate through the year.

Underlying operating profit came in at €5.2bn as underlying sales grew 9.1% to €30.4bn.

"In a volatile and high-cost environment, we will deliver another year of strong underlying sales growth in 2023," said chief executive Hein Schumacher.

"We expect underlying sales growth for the full year to be above 5%, ahead of our multi-year range, with underlying price growth continuing to moderate through the year."

Croda International reported first-half results in line with its revised expectations, with pro forma sales down 6%, driven by reduced inventory levels in consumer, crop, and industrial markets.

While consumer care sales remained flat, life sciences saw an 8% increase excluding prior period Covid-19 lipid sales, and industrial specialties experienced a 20% decline after adjusting for divestment in the prior period. Despite lower profits, the firm maintained its interim dividend and expressed confidence in its future performance.

Share this article

Related Sharecast Articles

London open: Stocks gain as investors mull Rightmove data; inflation eyed
(Sharecast News) - London stocks edged higher early trade on Monday as investors mulled the latest UK house price figures and looked ahead to key inflation data later in the week.
London pre-open: Stocks seen up as investors mull Rightmove data
(Sharecast News) - London stocks were set to rise at the open on Monday as investors mulled the latest UK house price figures.
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
London midday: FTSE stays down; Auto Trader hit by downgrade
(Sharecast News) - London stocks were still in the red by midday on Friday, having taken their opening cue from a downbeat close on Wall Street.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.